The complex of Plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site

Abstract Background Malaria kills over 400,000 people each year and nearly half the world’s population live in at-risk areas. Progress against malaria has recently stalled, highlighting the need for developing novel therapeutics. The parasite haemoglobin degradation pathway, active in the blood stag...

Full description

Bibliographic Details
Main Authors: Jonathan M. Machin, Anastassia L. Kantsadi, Ioannis Vakonakis
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Malaria Journal
Subjects:
Online Access:https://doi.org/10.1186/s12936-019-3043-0